BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20572306)

  • 1. Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma.
    Donadon V; Balbi M; Valent F; Avogaro A
    World J Gastroenterol; 2010 Jun; 16(24):3025-32. PubMed ID: 20572306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.
    Donadon V; Balbi M; Mas MD; Casarin P; Zanette G
    Liver Int; 2010 May; 30(5):750-8. PubMed ID: 20331505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease.
    Donadon V; Balbi M; Ghersetti M; Grazioli S; Perciaccante A; Della Valentina G; Gardenal R; Dal Mas M; Casarin P; Zanette G; Miranda C
    World J Gastroenterol; 2009 May; 15(20):2506-11. PubMed ID: 19469001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin.
    Donadon V; Balbi M; Casarin P; Vario A; Alberti A
    World J Gastroenterol; 2008 Oct; 14(37):5695-700. PubMed ID: 18837086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemia and chronic liver diseases on risk of hepatocellular carcinoma in Chinese patients with type 2 diabetes--National cohort of Taiwan Diabetes Study.
    Li CI; Chen HJ; Lai HC; Liu CS; Lin WY; Li TC; Lin CC
    Int J Cancer; 2015 Jun; 136(11):2668-79. PubMed ID: 25387451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection.
    Kawaguchi T; Taniguchi E; Morita Y; Shirachi M; Tateishi I; Nagata E; Sata M
    Liver Int; 2010 Mar; 30(3):479-86. PubMed ID: 20040053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the risk of hepatitis B-related cirrhosis combined with type 2 diabetes mellitus for the occurrence of primary hepatocellular carcinoma].
    Zhang LL; Li YF; Zhang C; Wu XF; Ma Y; Li L
    Zhonghua Gan Zang Bing Za Zhi; 2019 Oct; 27(10):788-792. PubMed ID: 31734994
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan.
    Tateishi R; Matsumura T; Okanoue T; Shima T; Uchino K; Fujiwara N; Senokuchi T; Kon K; Sasako T; Taniai M; Kawaguchi T; Inoue H; Watada H; Kubota N; Shimano H; Kaneko S; Hashimoto E; Watanabe S; Shiota G; Ueki K; Kashiwabara K; Matsuyama Y; Tanaka H; Kasuga M; Araki E; Koike K;
    J Gastroenterol; 2021 Mar; 56(3):261-273. PubMed ID: 33427937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma in a large cohort of type 2 diabetes patients.
    Giorda CB; Picariello R; Tartaglino B; Nada E; Costa G; Manti R; Monge L; Gnavi R
    Diabetes Res Clin Pract; 2023 Jun; 200():110684. PubMed ID: 37100229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2.
    Babic N; Valjevac A; Zaciragic A; Avdagic N; Zukic S; Hasic S
    Med Arch; 2019 Jun; 73(3):163-168. PubMed ID: 31404127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Diabetes and Glycemic Control on Risk of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen.
    Cheuk-Fung Yip T; Wai-Sun Wong V; Lik-Yuen Chan H; Tse YK; Pik-Shan Kong A; Long-Yan Lam K; Chung-Yan Lui G; Lai-Hung Wong G
    Clin Gastroenterol Hepatol; 2018 May; 16(5):765-773.e2. PubMed ID: 29246694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study.
    Tsai JF; Chang WY; Jeng JE; Ho MS; Lin ZY; Tsai JH
    Liver; 1994 Apr; 14(2):98-102. PubMed ID: 7515142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of postoperative glycemic control on recurrence after curative resection in diabetics with hepatitis C virus-related hepatocellular carcinoma.
    Kaneda K; Uenishi T; Takemura S; Shinkawa H; Urata Y; Sakae M; Yamamoto T; Kubo S
    J Surg Oncol; 2012 May; 105(6):606-11. PubMed ID: 22065536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic load in relation to hepatocellular carcinoma among patients with chronic hepatitis infection.
    Lagiou P; Rossi M; Tzonou A; Georgila C; Trichopoulos D; La Vecchia C
    Ann Oncol; 2009 Oct; 20(10):1741-5. PubMed ID: 19528361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.
    Benvegnù L; Fattovich G; Noventa F; Tremolada F; Chemello L; Cecchetto A; Alberti A
    Cancer; 1994 Nov; 74(9):2442-8. PubMed ID: 7922998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes and hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B.
    Li Q; Li WW; Yang X; Fan WB; Yu JH; Xie SS; Liu L; Ma LX; Chen SJ; Kato N
    Int J Cancer; 2012 Sep; 131(5):1197-202. PubMed ID: 22052244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.
    Han YF; Zhao J; Ma LY; Yin JH; Chang WJ; Zhang HW; Cao GW
    World J Gastroenterol; 2011 Oct; 17(38):4258-70. PubMed ID: 22090781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.